SCGB2A2 and breast cancer: Previous studies have shown an association between the expression of Mammaglobin A (MGB-1), which is highly homologous to Mammaglobin B, and less aggressive breast cancer phenotype, providing independent prognostic information for cancer patients' survival outcomes [30-32].